Bids Are Invited For Acquisition Of Pharmacological Materials From Process 23079.254162/2025-14

Atropine Sulfate Dosage: 0.25, Use: Injectable Solution, Bromopride Dosage: 5, Presentation: Injectable, Bupivacaine Hydrochloride Purity: 0.5%, Application: Isobaric, Presentation: Injectable Solution, Captopril Concentration: 25, Cephalexin Dosage: 500, 10/11/2025 - 13:13:02, 10/11/2025 - 13:13:03, Cefepime Hydrochloride Concentration: 1, Pharmaceutical Form: Lyophilic Powder For Injection, Ketoprofen Dosage: 50, Clindamycin Dosage: 150, Dexmedetomidine Hydrochloride Concentration: 100, Pharmaceutical Form: Injectable Solution, Diazepam Dosage: 5, Dipyrone Sodium Dosage: 500, Doxycycline Dosage: 100 Mg, Droperidol Concentration: 2, 50, Indication: Injectable Solution, Enoxaparin Concentration: 100, Additional Features 1: Prefilled Syringe, Epinephrine Dosage: 1Mg/Ml, Scopolamine Butylbromide Dosage: 10, Gentamicin Dosage: 40, Application: Injectable Solution, Glucose Concentration: 5%, Additional Features: Closed System, Losartan Potassium Dosage: 50, Meropenem Dosage: 500 Mg, Metoclopramide Hydrochloride Dosage: 5 Mg/Ml, Metronidazole Dosage: 5Mg/Ml, Neostigmine Methylsulfate Dosage: 0.5, Paracetamol Tablet Dosage: 500, Petrolatum Physical Appearance: Liquid, Type: Laxative, Use: Oral, Rocuronium Bromide Dosage: 10, Ropivacaine Hydrochloride Dosage: 1%